Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA149159
Max Phase: Preclinical
Molecular Formula: C12H5Br5O3
Molecular Weight: 596.69
Molecule Type: Small molecule
Associated Items:
ID: ALA149159
Max Phase: Preclinical
Molecular Formula: C12H5Br5O3
Molecular Weight: 596.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1cc(Br)c(Br)c(Br)c1Oc1cc(Br)cc(Br)c1O
Standard InChI: InChI=1S/C12H5Br5O3/c13-4-1-6(15)11(19)8(2-4)20-12-7(18)3-5(14)9(16)10(12)17/h1-3,18-19H
Standard InChI Key: WMMMSBGZKIDZDQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 596.69 | Molecular Weight (Monoisotopic): 591.6156 | AlogP: 6.70 | #Rotatable Bonds: 2 |
Polar Surface Area: 49.69 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.85 | CX Basic pKa: | CX LogP: 6.71 | CX LogD: 4.00 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.38 | Np Likeness Score: 0.98 |
1. de la Fuente JA, Manzanaro S, Martín MJ, de Quesada TG, Reymundo I, Luengo SM, Gago F.. (2003) Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product., 46 (24): [PMID:14613323] [10.1021/jm030957n] |
2. Hanif N, Tanaka J, Setiawan A, Trianto A, de Voogd NJ, Murni A, Tanaka C, Higa T.. (2007) Polybrominated diphenyl ethers from the Indonesian sponge Lamellodysidea herbacea., 70 (3): [PMID:17311456] [10.1021/np0605081] |
3. Fu X, Schmitz FJ, Govindan M, Abbas SA, Hanson KM, Horton PA, Crews P, Laney M, Schatzman RC.. (1995) Enzyme inhibitors: new and known polybrominated phenols and diphenyl ethers from four Indo-Pacific Dysidea sponges., 58 (9): [PMID:7494145] [10.1021/np50123a008] |
4. Calcul L, Chow R, Oliver AG, Tenney K, White KN, Wood AW, Fiorilla C, Crews P.. (2009) NMR strategy for unraveling structures of bioactive sponge-derived oxy-polyhalogenated diphenyl ethers., 72 (3): [PMID:19323567] [10.1021/np800737z] |
5. Liu H, Lohith K, Rosario M, Pulliam TH, O'Connor RD, Bell LJ, Bewley CA.. (2016) Polybrominated Diphenyl Ethers: Structure Determination and Trends in Antibacterial Activity., 79 (7): [PMID:27399938] [10.1021/acs.jnatprod.6b00229] |
Source(1):